US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Aug 22, 2024 (2 years ago)

Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility

What was recalled

Tirzepatide 2 mL (10 mg/mL) and 20 mg/mL, 2mL Multidose SC Injection vials, Compounded Rx Product, ProRx 267-565-7008, NDC 84139-210-01

Recalling firm
ProRx LLC
NDC code
84139-210-01
Origin
PA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0651-2024

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Tirzepatide recalls

See all